For the fourth year in a row, the University of Notre Dame’s John J. Reilly Center for Science, Technology and Values has released a list of emerging ethical dilemmas and policy issues in science and technology that we should be talking about in the coming year.
Thomson Reuters has named Timothy Beers, the University of Notre Dame Chair of Astrophysics, and Prashant Kamat, the Rev. John A. Zahm, C.S.C., Professor of Science, to its 2016 Highly Cited Researchers list. After Reuters analyzed Essential Science Indicators that included 128,887 highly cited papers ranked in the top 1 percent by total citations, the work of Beers and Kamat stood out as being among the most valuable and significant in their fields.
NDnano is now accepting applications for the Center's summer 2017 NDnano Undergraduate Research Fellowship (NURF) program.
Diabetes is a metabolic disease in which the body has an inability to produce enough insulin. In the United States alone, it is estimated that the illness affects nearly 30 million diagnosed and undiagnosed people, and treatment often includes patients using an intravenous or IV method to get insulin into their system. This uncomfortable and inconvenient form of treatment can require anywhere from two to four injections a day, but a Notre Dame researcher is working to combat this problem with a less frequent, oral delivery system.
Matthew Webber tested a novel route for non-covalent protein modification and results reveal a new way to improve the stability of common protein drugs and extend shelf-life.